MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Press Releases: Archives for November 2016

MotherToBaby Launches New Observational Study of Mepolizumab (Nucala®) in Pregnancy

BRENTWOOD, TN – MotherToBaby Pregnancy Studies, conducted by the Organization of Teratology Information Specialists (OTIS), has launched a new observational study of mepolizumab (Nucala®) in pregnancy, a new medication for the treatment of severe asthma. This study aims to provide crucial information on the safety of this medication in pregnancy by following asthmatic women during their pregnancy and following their child up to one year of age. Given that untreated asthma can put both the mother …

Read More...

Let’s Stay in Touch

Our e-Newsletter brings you the latest information, news, and resources from the experts at MotherToBaby.

Sign Up Now

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.